Fabrication of gastro-floating sustained-release etoricoxib and famotidine tablets: design, optimization, in-vitro, and in-vivo evaluation

References

• Aanisah N, Wardhana YW, Chaerunisaa AY, Budiman A. 2022. Review on modification of glucomannan as an excipient in solid dosage forms. Polymers. 14(13):2550. doi: 10.3390/polym14132550.
   PubMed Web of Science ®Google Scholar
• Aashigari S, G R SS, Vykuntam U, Potnuri N. 2019. Stability studies of pharmaceutical products. World J Pharm Res. 8:479–492. doi: 10.20959/wjpr20191-13872.
   Google Scholar
• Abdel Rahim S, Elkordy A. 2016. Application of xanthan gum as a sustained release agent. In: Butler M, editor. Xanthan gum: applications and research studies. Hauppauge: Nova Science Publishers; p. 67–96.
   Google Scholar
• Abrahamsson B, Alpsten M, Hugosson M, Jonsson UE, Sundgren M, Svenheden A, Tölli J. 1993. Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release (ER) tablets. Pharm Res. 10(5):709–714. doi: 10.1023/A:1018959732744.
   PubMed Web of Science ®Google Scholar
• Acharya S, Pandey J, Joshi HP, Parajuli G, Poudel N, Poudel S, Gurung S. 2022. Formulation and evaluation of gastro retentive floating tablet of amlodipine besylate using natural organic polymers. Int J App Pharm. 14:227–234. doi: 10.22159/ijap.2022v14i4.44600.
   PubMedGoogle Scholar
• Ahmadi M, Bekeschus S, Weltmann KD, von WT, Wende K. 2022. Non-steroidal anti-inflammatory drugs: recent advances in the use of synthetic COX-2 inhibitors. RSC Med Chem. 13(5):471–496. doi: 10.1039/D1MD00280E.
   PubMedGoogle Scholar
• Ai T, Shang L, He C, Teng Y, Ren C, Zhou P, Wang L, Li J, Li B. 2019. Development of multi-layered gastric floating tablets based on konjac glucomannan: a modified calcium supplement with enhanced bioavailability. Food Funct. 10(10):6429–6437. doi: 10.1039/C9FO01107B.
   PubMed Web of Science ®Google Scholar
• Ain S, Kumar B, Pathak K. 2017. Development and characterization of controlled release famotidine matrix tablets containing complexes. Int J App Pharm. 9(4):38–46. doi: 10.22159/ijap.2017v9i4.18859.
   PubMedGoogle Scholar
• Albadry AA, Ali WK, Al-Saady FA. 2017. Formulation and evaluation of prochlorperazine maleate sustained release floating tablet. Int J Pharm Pharm Sci. 9(2):89. doi: 10.22159/ijpps.2017v9i2.15665.
   Google Scholar
• Aleti R, Baratam SR, Jagirapu B, Kudamala S. 2021. Formulation and evaluation of metformin hydrochloride and gliclazide sustained release bilayer tablets: a combination therapy in management of diabetes. Int J App Pharm. 13:343–350. doi: 10.22159/ijap.2021v13i5.41339.
   PubMedGoogle Scholar
• Apeji YE, Olayemi OJ, Anyebe SN, Oparaeche C, Orugun OA, Olowosulu AK, Oyi AR. 2019. Impact of binder as a formulation variable on the material and tableting properties of developed co-processed excipients. SN Appl. Sci. 1(6):561. doi: 10.1007/s42452-019-0585-2.
   Web of Science ®Google Scholar
• Arza RAK, Gonugunta CSR, Veerareddy PR. 2009. Formulation and evaluation of swellable and floating gastroretentive ciprofloxacin hydrochloride tablets. AAPS PharmSciTech. 10(1):220–226. doi: 10.1208/s12249-009-9200-y.
   PubMed Web of Science ®Google Scholar
• Bachra Y, Grouli A, Damiri F, Zhu XX, Talbi M, Berrada M. 2022. Synthesis, characterization, and swelling properties of a new highly absorbent hydrogel based on carboxymethyl guar gum reinforced with bentonite and silica particles for disposable hygiene products. ACS Omega. 7(43):39002–39018. doi: 10.1021/acsomega.2c04744.
   PubMed Web of Science ®Google Scholar
• Bello AE, Kent JD, Holt RJ. 2015. Gastroprotective efficacy and safety of single-tablet ibuprofen/famotidine vs ibuprofen in older persons. Phys Sportsmed. 43(3):193–199. doi: 10.1080/00913847.2015.1066229.
   PubMed Web of Science ®Google Scholar
• Bello AE. 2012. DUEXIS® (ibuprofen 800 mg, famotidine 26.6 mg): a new approach to gastroprotection for patients with chronic pain and inflammation who require treatment with a nonsteroidal anti-inflammatory drug. Ther Adv Musculoskelet Dis. 4(5):327–339. doi: 10.1177/1759720X12444710.
   PubMedGoogle Scholar
• Bruschi ML. 2015. 6 – Drug delivery systems. In: Bruschi ML, editor. Strategies to modify the drug release from pharmaceutical systems. Sawston: Woodhead Publishing; p. 87–194.
   Google Scholar
• Chalmers J. 2005. Infrared spectroscopy|Sample presentation. In: Worsfold P, Townshend A, Poole C, editors. Encyclopedia of analytical science. 2nd ed. Amsterdam: Elsevier; p. 402–415.
   Google Scholar
• Das A, Nayak AK, Mohanty B, Panda S. 2011. Solubility and dissolution enhancement of etoricoxib by solid dispersion technique using sugar carriers. ISRN Pharm. 2011:819765. doi: 10.5402/2011/819765.
   PubMedGoogle Scholar
• Deepika KR, Sharma B. 2020. Formulation and evaluation of floating tablet. World J Pharm Res. 6:238–247.
   Google Scholar
• Djebbar M, Chaffai N, Bouchal F. 2020. Development of floating tablets of metformin HCl by thermoplastic granulation. Part II: in vitro evaluation of the combined effect of acacia Gum/HPMC on biopharmaceutical performances. Adv Pharm Bull. 10(3):399–407. doi: 10.34172/apb.2020.048.
   PubMed Web of Science ®Google Scholar
• DUEXIS. 2023. DUEXIS | (ibuprofen and famotidine) tablets 800 mg/26.6 mg. [accessed 2023 Feb 22]. https://www.duexis.com/
   Google Scholar
• Emara LH, Abdou AR, El-Ashmawy AA, Mursi NM. 2014. Preparation and evaluation of metronidazole sustained release floating tablets. Int J Pharm Pharm Sci. 6:198–204.
   Web of Science ®Google Scholar
• Feng X, Tian M, Zhang W, Mei H. 2018. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: a meta-analysis. PLOS One. 13(1):e0190798. doi: 10.1371/journal.pone.0190798.
   PubMed Web of Science ®Google Scholar
• Fuhrman LC. 2006. Ansel’s pharmaceutical dosage forms and drug delivery systems. Am J Pharm Educ. 70(3):71.
   Google Scholar
• Gordon M. 2008. Process considerations in reducing tablet friability and their effect on in vitro dissolution. Drug Dev Ind Pharm. 20(1):11–29. doi: 10.3109/03639049409047211.
   Google Scholar
• Hu X, Wang K, Yu M, He P, Qiao H, Zhang H, Wang Z. 2019. Characterization and antioxidant activity of a low-molecular-weight xanthan gum. Biomolecules. 9(11):730. doi: 10.3390/biom9110730.
   PubMed Web of Science ®Google Scholar
• Islam MS, Narurkar MM. 1993. Solubility, stability and ionization behaviour of famotidine. J Pharm Pharmacol. 45(8):682–686. doi: 10.1111/j.2042-7158.1993.tb07088.x.
   PubMed Web of Science ®Google Scholar
• Jaganathan K, Venkateswaramurthy N, Neelamegarajan R, Kannan C, Sambathkumar K. 2022. Experimental design approach to fabricate and optimize floating tablets of levofloxacin for helicobacter pylori infection. Int J App Pharm. 14:100–113. doi: 10.22159/ijap.2022v14i6.45809.
   PubMedGoogle Scholar
• Jain AK, Söderlind E, Viridén A, Schug B, Abrahamsson B, Knopke C, Tajarobi F, Blume H, Anschütz M, Welinder A, et al. 2014. The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets. J Control Release. 187:50–58. doi: 10.1016/j.jconrel.2014.04.058.
   PubMed Web of Science ®Google Scholar
• Jonna S, Bapatu HR, Subbappa P, Saravanan K. 2023. A QBD with the fractional factorial design was used to match the similarity between ranolazine extended-release tablets 500 mg and 1000 mg. Int J App Pharm. 15:98–105. doi: 10.22159/ijap.2023v15i2.47241.
   Google Scholar
• Kam LY, Wong JW, Yuen KH. 2023. In vivo evaluation of thiamine hydrochloride with gastro-retentive drug delivery in healthy human volunteers using gamma scintigraphy. Pharmaceutics. 15(2):691. doi: 10.3390/pharmaceutics15020691.
   PubMed Web of Science ®Google Scholar
• Kanwar N, Kumar R, Sarwal A, Sinha VR. 2016. Preparation and evaluation of floating tablets of pregabalin. Drug Dev Ind Pharm. 42(4):654–660. doi: 10.3109/03639045.2015.1062895.
   PubMed Web of Science ®Google Scholar
• Karakus S, Tan E, Ilgar M, Kahyaoglu IM, Şahin YM, Mansuroglu DS. 2019. Preparation, characterization, and swelling behavior of PEGylated Guar Gum @ Ag nanoparticles. IntechOpen. doi: 10.5772/intechopen.90227.
   Google Scholar
• Khan K, Naeem M, Ali A, Rehman NU, Nawaz Z, Akram MR, et al. 2016. Assessment of guar and xanthan gum based floating drug delivery system containing mefenamic acid. Acta Pol Pharm. 73(5):1287–1297.
   PubMed Web of Science ®Google Scholar
• Kopp S. 2006. Stability testing of pharmaceutical products in a global environment. RAJ Pharma. 5:291–294.
   Google Scholar
• Li B, Xia J, Wang Y, Xie B. 2005. Grain-Size Effect on the Structure and Antiobesity Activity of Konjac Flour. J Agric Food Chem. 53(19):7404–7407. doi: 10.1021/jf050751q.
   PubMed Web of Science ®Google Scholar
• Majumder KK, Kumar M, Pahwa R, Lamba AK, Shankar R, Tiwari A, Tiwari V, Rishabh. 2021. Formulation and characterization of floating tablet dosage form of dual delivery of drug curcumin and berberine hydrochloride using simultaneous estimation by UV spectroscopy. Int J App Pharm. 13:306–310. doi: 10.22159/ijap.2021v13i5.42098.
   PubMedGoogle Scholar
• Martina SD, Vesta KS, Ripley TL. 2005. Etoricoxib: a highly selective COX-2 inhibitor. Ann Pharmacother. 39(5):854–862. doi: 10.1345/aph.1E543.
   PubMed Web of Science ®Google Scholar
• Mayavanshi AV, Gajjar SS. 2008. Floating drug delivery systems to increase gastric retention of drugs: a review. Res J Pharm Technol. 1(4):345–348.
   Google Scholar
• Menache A. 2000. Healthy human volunteers and informed consent. Med Law. 19(3):2022. https://pubmed.ncbi.nlm.nih.gov/11143887/
   Google Scholar
• Mummaneni V, Vasavada RC. 1990. Solubilization and dissolution of famotidine from solid glass dispersions of xylitol. Int J Pharm. 66(1-3):71–77. doi: 10.1016/0378-5173(90)90386-I.
   Google Scholar
• Muthukumar M, Mohan D, Rajendran M. 2003. Optimization of mix proportions of mineral aggregates using Box Behnken design of experiments. Cem Concr Compos. 25(7):751–758. doi: 10.1016/S0958-9465(02)00116-6.
   Web of Science ®Google Scholar
• Nabarawi MAE, Teaima MH, El-Monem RAA, Nabarawy NAE, Gaber DA. 2017. Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl. Drug Des Devel Ther. 11:1081–1093. doi: 10.2147/DDDT.S131936.
   PubMed Web of Science ®Google Scholar
• Nerurkar J, Jun HW, Price JC, Park MO. 2005. Controlled-release matrix tablets of ibuprofen using cellulose ethers and carrageenans: effect of formulation factors on dissolution rates. Eur J Pharm Biopharm. 61(1–2):56–68. doi: 10.1016/j.ejpb.2005.03.003.
   PubMed Web of Science ®Google Scholar
• Niharika MG, Krishnamoorthy K, Akkala M. 2018. Overview on floating drug delivery system. Int J App Pharm. 10(6):65–71. doi: 10.22159/ijap.2018v10i6.28274.
   PubMedGoogle Scholar
• Nucoxia MR Tablet: View Uses, Side Effects, Price and Substitutes. 1mg. 2023. [accessed 2023 Feb 25]. https://www.1mg.com/drugs/nucoxia-mr-tablet-69933
   Google Scholar
• Nur A, Elamin A, Osman Z, Ahmed S. 2014. Influence of type and content of guar gum as a disintegrant and production technique on attributes of immediate release tablets. Am J PharmTech Res. 4.
   Google Scholar
• Omidian H, Park K. 2008. Swelling agents and devices in oral drug delivery. J Drug Delivery Sci Technol. 18(2):83–93. doi: 10.1016/S1773-2247(08)50016-5.
   Web of Science ®Google Scholar
• Parente L. 2001. Pros and cons of selective inhibition of cyclooxygenase-2 versus dual lipoxygenase/cyclooxygenase inhibition: is two better than one? J Rheumatol. 28(11):2375–2382.
   PubMed Web of Science ®Google Scholar
• Parida DR, Kharia AA, Choudhary NK. 2021. Optimization in-vitro and in-vivo evaluation of floating tablet of tetrabenazine. NVEO. 8:12565–12579.
   Google Scholar
• Patel M, Khan MA. 2023. Optimization, development and evaluation of repaglinide controlled release gastro-retentive floating tablet using central composite design. Int J App Pharm. 15:218–226. doi: 10.22159/ijap.2023v15i1.46493.
   PubMedGoogle Scholar
• Paudel P, Noori H, Poudel B, Shakya S, Bhatta P, Lamichhane S. 2014. Influence of different grades and concentrations of hydroxypropyl methyl cellulose on the release of metformin hydrochloride. World J Pharm Sci. 2(9):966–980. https://wjpsonline.com/index.php/wjps/article/view/influence-grades-concentrations-hmc-release-metformin
   Google Scholar
• Pore Y, Mane M, Mangrule V, Chopade A, Gajare P. 2018. Preparation, characterization, and evaluation of anti-inflammatory activity of etoricoxib loaded Soluplusâ® nanocomposites. Int J App Pharm. 10(6):268–274. doi: 10.22159/ijap.2018v10i6.26042.
   PubMedGoogle Scholar
• Prabakaran B, Elango K, Kumar KR, Jaison D. 2016. Formulation development and evaluation of gastroretentive bilayer floating tablets of simvastatin and telmisartan. Int J Pharma Res Rev. 5(1):9–18. https://www.semanticscholar.org/paper/Formulation-Development-and-Evaluation-of-Bilayer-Prabakaran-Elango/5da97f2c025f3fab417e2e1fddc15dfd3872f629
   Google Scholar
• Prasad S, Kummara MR, Ramasubba Reddy P, Nagella SR, Krishna Rao KSV, Subha MC. 2012. Synthesis and characterisation of guar gum-g-Poly(Acrylamidoglycolic acid) by redox initiator. Ind J Adv Chem Sci. 1:28–32.
   Google Scholar
• Pushpa MSS, Rajeswari TR. 2021. RP-HPLC quantifiable technique development for evaluating pregabalin and etoricoxib combination in tablet and bulk kinds. Int J App Pharm. 13:152–156. doi: 10.22159/ijap.2021v13i6.42759.
   PubMedGoogle Scholar
• Rahamathulla M, Saisivam S, Alshetaili A, Hani U, Gangadharappa HV, Alshehri S, Ghoneim MM, Shakeel F. 2021. Design and evaluation of losartan potassium effervescent floating matrix tablets: in vivo X-ray imaging and pharmacokinetic studies in albino rabbits. Polymers. 13(20):3476. doi: 10.3390/polym13203476.
   PubMed Web of Science ®Google Scholar
• Razavi M, Karimian H, Yeong CH, Chung LY, Nyamathulla S, Noordin MI. 2015. Gamma scintigraphic evaluation of floating gastroretentive tablets of metformin HCl using a combination of three natural polymers in rabbits. Drug Des Devel Ther. 9:4373–4386. doi: 10.2147/DDDT.S86263.
   PubMed Web of Science ®Google Scholar
• Saini S, Bhardwaj BY, Chhabra J, Kumar M, Pahwa R. 2022. In vivo monitoring strategies for evaluation of floating drug delivery systems. Int J App Pharm. 14:28–33. doi: 10.22159/ijap.2022v14i6.45906.
   Google Scholar
• Sapkal S, Adhao VS, Thenge R, Darakhe R, Shinde A, Natthuji V. 2020. ÖZ formulation and characterization of solid dispersions of etoricoxib using natural polymers 8 SAPKAL et al. Solid dispersions of etoricoxib using natural polymers. Turk J Pharm Sci. 17(1):7–19. doi: 10.4274/tjps.galenos.2018.04880.
   PubMed Web of Science ®Google Scholar
• Sapkal S, Adhao VS, Thenge R, Darakhe R, Shinde S, Shrikhande V. 2018. Formulation and characterization of etoricoxib solid dispersion using natural polymers. TJPS. 17(1):7–19. doi: 10.4274/tjps.04880.
   Google Scholar
• Schiff M, Peura D. 2012. HZT-501 (DUEXIS®; ibuprofen 800 mg/famotidine 26.6 mg) gastrointestinal protection in the treatment of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Expert Rev Gastroenterol Hepatol. 6(1):25–35. doi: 10.1586/egh.11.88.
   PubMed Web of Science ®Google Scholar
• ScienceDirect Topics. 2023. Etoricoxib – an overview. [accessed 2023 Feb 25] https://www.sciencedirect.com/topics/chemistry/etoricoxib
   Google Scholar
• ScienceDirect Topics. 2023. Factorial design – an overview. [accessed 2023 Feb 25]. https://www.sciencedirect.com/topics/materials-science/factorial-design
   Google Scholar
• Shoman NA, Saady M, Teaima M, Abdelmonem R, El-Nabarawi MA, Elhabal SF. 2023. Merging konjac glucomannan with other copolymeric hydrogels as a cutting-edge liquid raft system for dual delivery of etoricoxib and famotidine. Drug Deliv. 30(1):2189630. doi: 10.1080/10717544.2023.2189630.
   PubMed Web of Science ®Google Scholar
• SVN P, Pappula N, Naik VV, Kolapalli VRM. 2023. Development and evaluation of gastric floating tablets of riboflavin using Box-Behnken design. Int J App Pharm. 294–302. doi: 10.22159/ijap.2023v15i5.48414.
   PubMedGoogle Scholar
• Taghizadeh Davoudi E, Ibrahim Noordin M, Kadivar A, Kamalidehghan B, Farjam AS, Akbari Javar H. 2013. Preparation and characterization of a gastric floating dosage form of capecitabine. Biomed Res Int. 2013:e495319–8. doi: 10.1155/2013/495319.
   PubMed Web of Science ®Google Scholar
• Teaima M, Abdelmonem R, Saady M, El-Nabarawi M, Shoman NA. 2022. Comprehensive overview on recent updates of gastroretentive raft-forming systems. Int J App Pharm. 14:40–48. doi: 10.22159/ijap.2022v14i3.44098.
   Google Scholar
• Teaima M, Hamid MMA, Shoman NA, Jasti BR, El-Nabarawi MA. 2020. Promising swellable floating bupropion tablets: formulation, in vitro/in vivo evaluation and comparative pharmacokinetic study in human volunteers. Drug Des Devel Ther. 14:2741–2757. doi: 10.2147/DDDT.S258571.
   PubMed Web of Science ®Google Scholar
• Thakur S, Ramya K, Shah DK, Raj K. 2021. Floating drug delivery system. J Drug Deliv Ther. 11(3-S):125–130. doi: 10.22270/jddt.v11i3-S.4828.
   Google Scholar
• The National Formulary. 2011. The United States Pharmacopeia 2011: USP 35: NF 30 . Rockville: United States Pharmacopeial Convention.
   Google Scholar
• Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E. 2018. Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib. Clin Pharmacol. 10:43–51. doi: 10.2147/CPAA.S161024.
   PubMed Web of Science ®Google Scholar
• Vinchurkar K, Sainy J, Khan MA, Mane S, Mishra DK, Dixit P. 2022. Features and facts of a gastroretentive drug delivery system – A review. Turk J Pharm Sci. 19(4):476–487. doi: 10.4274/tjps.galenos.2021.44959.
   PubMed Web of Science ®Google Scholar
• Wang LX, Lee AR, Yuan Y, Wang XM, Lu TJ. 2020. Preparation and FTIR, Raman and SEM characterizations of konjac glucomannan-KCl electrogels. Food Chem. 331:127289. doi: 10.1016/j.foodchem.2020.127289.
   PubMed Web of Science ®Google Scholar
• Wang SQ, Huang GQ, Du YL, Xiao JX. 2017. Modification of konjac glucomannan by reduced-pressure radio-frequency air plasma. Int J Food Eng. 13(8):20160377. doi: 10.1515/ijfe-2016-0377.
   Web of Science ®Google Scholar
• WHO. 2019. WHO expert committee on specifications for pharmaceutical preparations: fifty-third report. Geneva: World Health Organization.
   Google Scholar
• World Medical Association. 2022. WMA declaration of Helsinki – Ethical principles for medical research involving human subjects. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
   Google Scholar
• Zarghi A, Arfaei S. 2011. Selective COX-2 inhibitors: a review of their structure-activity relationships. Iran J Pharm Res. 10(4):655–683.
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen J, Yang FQ. 2014. Konjac glucomannan, a promising polysaccharide for OCDDS. Carbohydr Polym. 104:175–181. doi: 10.1016/j.carbpol.2013.12.081.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. 2010. PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed. 99(3):306–314. doi: 10.1016/j.cmpb.2010.01.007.
   PubMed Web of Science ®Google Scholar